company background image
OPTI

OptiBiotix Health AIM:OPTI Stock Report

Last Price

UK£0.15

Market Cap

UK£13.9m

7D

-25.6%

1Y

-63.3%

Updated

07 Dec, 2022

Data

Company Financials +
OPTI fundamental analysis
Snowflake Score
Valuation2/6
Future Growth0/6
Past Performance2/6
Financial Health6/6
Dividends0/6

OPTI Stock Overview

OptiBiotix Health Plc, a life sciences company, engages in the research and development of microbiome modulators primarily in the United Kingdom.

OptiBiotix Health Plc Competitors

Price History & Performance

Summary of all time highs, changes and price drops for OptiBiotix Health
Historical stock prices
Current Share PriceUK£0.15
52 Week HighUK£0.48
52 Week LowUK£0.15
Beta1.57
1 Month Change-18.67%
3 Month Change-8.96%
1 Year Change-63.25%
3 Year Change-67.20%
5 Year Change-76.89%
Change since IPO69.44%

Recent News & Updates

Recent updates

Shareholders In OptiBiotix Health (LON:OPTI) Should Look Beyond Earnings For The Full Story

Jun 24
Shareholders In OptiBiotix Health (LON:OPTI) Should Look Beyond Earnings For The Full Story

Shareholder Returns

OPTIGB BiotechsGB Market
7D-25.6%2.1%0.1%
1Y-63.3%-35.1%-8.8%

Return vs Industry: OPTI underperformed the UK Biotechs industry which returned -35.1% over the past year.

Return vs Market: OPTI underperformed the UK Market which returned -8.8% over the past year.

Price Volatility

Is OPTI's price volatile compared to industry and market?
OPTI volatility
OPTI Average Weekly Movement8.4%
Biotechs Industry Average Movement7.6%
Market Average Movement5.8%
10% most volatile stocks in GB Market11.0%
10% least volatile stocks in GB Market2.9%

Stable Share Price: OPTI is more volatile than 75% of UK stocks over the past 3 months, typically moving +/- 8% a week.

Volatility Over Time: OPTI's weekly volatility (8%) has been stable over the past year, but is still higher than 75% of UK stocks.

About the Company

FoundedEmployeesCEOWebsite
201212Stephen O'Harahttps://www.optibiotix.com

OptiBiotix Health Plc, a life sciences company, engages in the research and development of microbiome modulators primarily in the United Kingdom. The company identifies and develops microbial strains, compounds, and formulations for use in food ingredients, supplements, and active compounds that impacts human physiology deriving potential health benefits. Its products include Slimbiome, a natural ingredient, which offers a healthy and hunger-free weight management system; SlimBiome Medical, a natural supplement for weight management; CholBiome, a food supplement for maintaining healthy levels of cholesterol; Lactobacillus plantarum LPLDL, a probiotic that aids elements of cardiovascular and wellbeing; LPGOS, a galactooligosaccharid that is used in food products and applications, which helps in reducing cardiovascular risk factors and enhancing health; WellBiome, a functional fibre and mineral blend that supports health & wellbeing by promoting the diversity of the gut microbiome; and Sweetbiotix, a sweetener for use in food and beverages.

OptiBiotix Health Plc Fundamentals Summary

How do OptiBiotix Health's earnings and revenue compare to its market cap?
OPTI fundamental statistics
Market CapUK£13.91m
Earnings (TTM)UK£5.91m
Revenue (TTM)UK£1.26m

2.4x

P/E Ratio

11.1x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
OPTI income statement (TTM)
RevenueUK£1.26m
Cost of RevenueUK£544.47k
Gross ProfitUK£711.32k
Other Expenses-UK£5.20m
EarningsUK£5.91m

Last Reported Earnings

Jun 30, 2022

Next Earnings Date

n/a

Earnings per share (EPS)0.065
Gross Margin56.64%
Net Profit Margin470.44%
Debt/Equity Ratio0.0%

How did OPTI perform over the long term?

See historical performance and comparison